Investments in and Advances to Joint Ventures - Schedule of Reconciliation of Consolidated Joint Venture Equity (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Schedule Of Equity Method Investments [Line Items]
Company's share of accumulated equity	$ 35,365	$ 35,782
Basis differentials	1,367	1,099
Deferred development fees, net of portion related to the Company's interest	(132)	(136)
Amounts payable to the Company	2,007	2,627
Investments in and Advances to Joint Ventures, net	$ 38,607	$ 39,372